retatrutide phase 2 trial type 2 diabetes weight loss 2024 Retatrutide, an experimental weight-loss drug Lilly's triple agonist, retatrutide, successful – Investigational Triple-G Injectable Scores Two
Pay in 4 interest-free payments of $7.40 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13

























